The translocation which activates the Abl kinase has been succesfully targeted by using a specific small molecule inhibi

[answerhappygod]

The translocation which activates the Abl kinase has been succesfully targeted by
using a specific small molecule inhibitor called Gleevec.
blocking G-protein coupled receptors with small molecule inhibitors.
using the tyrosine kinase inhibitor Trastuzamab.
Using CRISPR-Cas9 to target the Bcr-Abl gene.